(1 - 9 von 34
)
Cell therapy biotech Affini-T gets $175M; KRAS is lead genomic ...medcitynews.com ›
medcitynews.com
· ... mutations that enable tumors to grow and spread,” Jak Knowles, Affini-T co-founder, president and CEO said in a prepared statement.
sortiert nach Relevanz / Datum